Survey of the Safe Harbor in the U.S. and Europe

Authors

Name

Brian D. Coggio

Person title

Of Counsel

Fish & Richardson litigation attorney Brian Coggio recently co-authored the article “Survey of the Safe Harbor in the United States and Europe” published by Bloomberg BNA on December 2, in the Pharmaceutical Law & Industry Report. The survey reviews the scope and history of protection afforded by the Safe Harbor including the so-called Bolar Exception, Bolar Exemption and the broad research exemptions that exist in Europe.

“Understanding the scope of the Safe Harbor in the U.S. and the regulatory research safe harbors in the EU and Canada will allow companies to take advantage of the best geographical locations in order to avoid infringement accusations in researching and developing pharmaceutical products.”

Authors: Brian Coggio, Ron Vogel

The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.

Survey of the Safe Harbor in the United States and Europe

Authors

Should the Experimental Use Exception Be Broadened?

Duty of Disclosure and Consistency Requirements for Statements to PTO and Other Government Agencies

The Final Word on an Alleged Infringer’s Intent in a Hatch-Waxman Safe Harbor Analysis

Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis

Federal Circuit to Consider the Relevance of an Alleged Infringer’s “Intent” in a Hatch-Waxman Safe Harbor Analysis

Fish Attorneys Author IP Litigator Article, "Regenxbio v. Sarepta: Make Sure You're Safely Within the Safe Harbor Before Using a 'Research Tool'"

REGENXBIO v. SAREPTA: Make Sure You're Safely Within the Safe Harbor Before Using a "Research Tool"

Users of Research Tools Take Note

Attorneys for Branded Companies Should Carefully Review ANDAs for Admissions Regarding Generic Infringement

First Circuit Finds Device Patent Improperly Listed in the Orange Book

How a Second Trump Presidency Could Shape IP

Texas Patent Litigation Monthly Wrap-Up: October 2024

Women’s Health Tech Entrepreneurs Combat Period Poverty and Increase Representation at the USPTO

Trade Secrets: A Powerful Alternative to Noncompete Agreements

Legal Alert: USPTO’s AFCP 2.0 Program to End December 14

Should the Experimental Use Exception Be Broadened?

Duty of Disclosure and Consistency Requirements for Statements to PTO and Other Government Agencies

Federal Circuit Finds Conventional Components Can Provide a Technological Advantage at Alice Step 1

Taking a Good Deposition, Part II: Asking the Right Kind of Questions and Asking Them in the Right Way

The Final Word on an Alleged Infringer’s Intent in a Hatch-Waxman Safe Harbor Analysis